Cargando…
New Generation Cardiac Contractility Modulation Device—Filling the Gap in Heart Failure Treatment
(1) Background: Heart failure (HF) is a major cause of morbidity and mortality throughout the world. Despite substantial progress in its prevention and treatment, mortality rates remain high. Device therapy for HF mainly includes cardiac resynchronization therapy (CRT) and the use of an implantable...
Autores principales: | Tint, Diana, Florea, Roxana, Micu, Sorin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572164/ https://www.ncbi.nlm.nih.gov/pubmed/31035648 http://dx.doi.org/10.3390/jcm8050588 |
Ejemplares similares
-
Cost‐effectiveness of a cardiac contractility modulation device in heart failure with normal QRS duration
por: Witte, Klaus, et al.
Publicado: (2020) -
Cardiac contractility modulation: a novel approach for the treatment of heart failure
por: Abi-Samra, Freddy, et al.
Publicado: (2016) -
Cardiac contractility modulation: mechanisms of action in heart failure with reduced ejection fraction and beyond
por: Tschöpe, Carsten, et al.
Publicado: (2018) -
Clinical effects of cardiac contractility modulation in heart failure with mildly reduced systolic function
por: Tschöpe, Carsten, et al.
Publicado: (2020) -
Editorial: Advances in cardiac imaging and heart failure management
por: Mandoli, Giulia Elena, et al.
Publicado: (2023)